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1. Introduction 
Deaths anaphylaxis related have always been very difficult in objectification in autopsies. So 
they are object of study for pathologists and legal doctors. In this work we want to propose 
a methodological protocol based on the various available diagnostic tools to use when an 
anaphylaxis related death is suspected.  
2. Pathogenesis 
The anaphylaxis is an allergic reaction. An allergic reaction is a spontaneous and exaggerate 
reaction of the body to a particular substance. These substances, called  allergens, cause 
production of antibodies when enter the body. The exposition with the substance happens 
by inhalation, ingestion, contact or inoculation of the allergen. Every substance can act as 
allergen. Among the more frequent substances we remember the heterologous proteins 
(hormone like insulin, vasopressin, parathormon; enzymes like trypsin, chemotrypsin, 
penicillinases; pollens, food like eggs, fish, hazel-nuts, cereals, beans, chocolate; antiserums,  
hymenoptera venom); polysaccharides (iron dextran); drugs (antibiotics like penicillins, 
cephalosporins, Amphotericin B, nitrofurantoin, local anesthetics like procaine and 
lidocaine; vitamins like thiamine and folic acid); diagnostic substances (iodated means of 
contrast, sodium dehydrocoled, sulfobromoftaleine); industrial chemical products (ethylene 
oxide). (Fauci et al., 2009) 
The concept of anaphylaxis comes from the study of the actinotoxins on the dogs’ arterial 
blood pressure (Richet, 1902). 
It is well known that the anaphylactic shock is an example of the immediate type of 
hypersensitivity reaction inducing a diffuse organ hypoperfusion. It has been defined 
(Delage & Irey, 1972) as the failure of the peripheral circulation induced by an antigen 
(allergen)-antibody reaction in already sensitized subjects for a foreign substance. Whenever 
the hypoperfusion is complicated by increased capillary permeability, a rapidly irreversible 
circulatory fatal damage occurs (anaphylactic death). 
Delage and Irey (Delage & Irey, 1972), in their clinico-pathological study of 43 validated 
cases of drug-induced fatal anaphylactic shock, the predominant role of penicillin, 
subsequently confirmed (Di Maio & Di Maio 2001; Menchel et al., 1987; Weeden, 1988), is 
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reported. In these as well as in other cases immunoglobulin E (IgE) antibodies have been 
tested to various allergens, present in contrast media (Di Maio & Di Maio 2001; Lang et al., 
1995; Pumphrey & Roberts, 2000; Risgaard et al., 2008), sera (Vance & Strassmann, 1942; 
Johann-Liang et. Al., 2011), insect venom (Pumphrey, 2000; Riches et al., 2001; Yunginger et 
al., 1991), and food (Di Maio & Di Maio 2001; Pumphrey, 2000; Pumphrey & Roberts, 2000; 
Yunginger et al., 1991) are thought to initiate anaphylactic reaction in patients previously 
sensitized towards that allergen (often unknowingly). 
A register including all fatal anaphylactic reactions in the UK is operative since 1992 
(Pumphrey, 2008). In France and Belgium since 2001 a university research team has founded 
the Allergy Vigilance Network, that in addition to reporting cases of severe anaphylaxis, to 
determine the prevalence of sensitization to risk allergens and screening and long-term 
monitoring of dangers related to new foods, ingredients and adjuvant sensitizing factors,  
with the French National Institute for Food Safety (AFSSA) and the Ministry of Consumer 
Affairs (DGCCRF) and various patient associations, also analyzes dangers related to the 
allergenicity of natural and modified food proteins (Moneret-Vautrin et al., 2002; Moneret-
Vautrin, 2007).  
Allergy depends on the individual “predisposition”. In certain people the contact between 
the allergen and the human body causes an abnormal immune reaction that clinically 
appears with the wide spectrum of manifestations of the allergic reaction (Crane, 2006; 
Liccardi et al., 2006) 
Hypersensitivity reaction can be classified according the four type of immuno-pathological 
reaction of Gell and Coombs (Fauci, 2009): 
- type I: they are the result of an IgE-mediated  reaction that leads to an immediate 
hypersensitivity 
- type II: IgG or IgM mediated. These antibodies are directed against cellular surface’s 
antigens altered by the drug that provoke a complement-mediated cytotoxicity.  
- type III: immuno-complexes mediated. The immunocomplexes’ dimensions determine 
the site of deposition and the consequent immunological damage. 
- type IV: retarded hypersensitivity. They come out by the interaction of the antigen with 
T lymphocyte and determine a cell-mediated reaction.  
Type I reaction is characterized by a rapid activation (in few minutes)of vasoactive and 
spasmogen substances by antibodies that are on the surface of the mastcells and basophils. 
It’s composed of three phases: 
1. sensitization, when the immune system come into contact with the allergen for the first 
time and stimulates IgE antibodies by B cells (the IgE production is  under the control of 
TH2 CD4+ that increases its production and under the control of TH1 that reduces the 
production). The IgE bind mastcells’ and basophils’ receptors making them sensible to a 
next exposition to the antigen. 
2. initial reaction: Immune system has a memory; so at the second exposition to the 
allergen there’s a binding between the antigen and the IgE antibodies localized on the 
mast-cells and basophils (sensitized). High affinity receptors (IgE) are almost 
exclusively on the mast-cells and on the basophils while low affinity receptors are also 
in other cytotypes (eosinophils, macrophages, platelets). 
When the allergen binds to the high affinity receptor there’s the activation of the 
mastcells that leads to the degranulation of the mastcells and release of primary 
mediators (preformed) such as histamine, adenosine, chemiotactic mediators (e.g. the 
ones for the eosinophils), enzyme (tryptases, kynases), proteoglicans. There’s also the 
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release of secondary mediators of ‘de novo’ synthesis such as leucothrienes, 
prostaglandines, platelets’ aggregation stimulation factors, cytokines, chemokines. In 
the first 30-60 minutes after exposition symptoms happen. Histamine is characterized 
by a very short half-life in the circulation, tryptase and chymase, are stable post-mortem 
(Edston et al., 2007; Nishio et al., 2005) and respectively used in post-mortem diagnosis 
of acute anaphylaxis (Edston, 2007; Nishio, 2005; Pumphrey, 2000; Riches et al., 2001; 
Schwartz, 1987; Yunginger et al., 1991). Tryptase is a serine protease stored mainly in 
mast cell granules, not found in circulating basophils, eosinophils, platelets or any other 
cell, represented by two varieties: an active free form () and an inactive tetramere () 
(Ansari et al., 1993; Schwartz et al. 1995).  
The former is a protein released from mast cell granules during anaphylactic reactions, 
the latter is a similar protein secreted by resting mast cells and raised in mastocytosis 
(Pumphrey & Roberts, 2000; Schwartz et al. 1995).  
Chymase is a mast cell-derived serine protease, characterized as an angiotensin II-
generating enzyme (Nishio, 2005) and used to determine mast cells and thus to assess 
the timing of wounds after deaths (Bonelli et al., 2003; Urata et al., 1990).  
It is quite stable in serum and a significant positive correlation between serum chymase 
and tryptase levels was found in post-mortem diagnosis of anaphylaxis (Nishio, 2005). 
Heterogeneity of human mast cells is known (Irani & Schwartz, 1994; Weidner & 
Austen, 1993) and recently different subsets of mast cells (MC) are distinguished by 
immunohistochemistry (Perskvist & Edston, 2007), as  follows: 
MC-TCs (formerly connective tissue mast cells) mainly composed of histamine, heparin, 
tryptase, chymase, cathepsin G and carboxypeptidase, preformed and stored in 
granules. 
 MC-T (formerly mucosal mast cells) lacking or containing only small amounts of 
chymase, carboxypeptidase and cathepsin. 
 MC-C lacking tryptase and not further characterized 
3. Late phase: after 2 hours from the initial response the presence of antigen is not 
necessary and the tissue infiltration begins by inflammatory cells (neutrophils, 
eosinophils, basophils, monocytes) with consequent tissue lesions (in particular 
epithelia and mucosas). 
This is the typical allergic reaction that usually brings to vasodilatation, skin rash, edema, 
itching; but the clinical spectrum is very wide and the allergic disturbs can be poor or get  
the death for anaphylactic shock.  
Anaphylaxis is the most dangerous among the allergic reaction and it is a severe systemic 
reaction, with an often sudden and important beginning, with an acute response that 
happens in a variable time from few seconds to few minutes after the antigen exposition. 
Anaphylaxis can be elicited for every concentration of the antigen (also minimal, sometimes 
it happens during skin test for drugs, etc.) (Bernstein et al., 2004; Blanton & Sutphin, 1949; 
Eleuterio Gonzàlez et al., 1997; Harris & Sure, 1950; Liccardi et al., 2006; Lockey et al., 1987; 
Riezzo, 2010; Weber-Mani & Pichler, 2008). 
The typical anaphylaxis consists of sudden weakness, itching and urticaria, chest 
oppression, respiratory distress (wheezing) followed by cardio-circulatory collapse. 
Symptoms maybe very variable and could be involved almost all the functions/apparatus. 
Could be involved: cardio-vascular system(tachycardia, hypotension, arrhythmias, 
ischemia/ myocardial  infarction, heart arrest, symptoms from hypoperfusion are constant), 
nervous system (vertigo, asthenia, syncope, convulsions), eye (conjunctival injection, 
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lachrymation), upper airway (nasal congestion, sneezing, hoarseness, stridor, pharyngeal or 
laryngeal edema, cough, obstruction, laryngospasm), lower airway (dyspnea, 
bronchospasm, tachypnea, involvement of the accessory respiratory muscles, cyanosis, 
respiratory arrest), skin (rash, erythema, itching, urticaria or urticarial reaction, edema, 
maculo-papular rash), gastrointestinal apparatus (nausea, vomiting, abdominal pain, 
diarrhea)(Crane et al. 2006; Fauci, 2009; Rovere-Querini, 2010). 
Lethal cases are mainly due to: acute respiratory distress derived by the glottis edema or by 
bronchial obstruction/bronchospasm; cardio-vascular collapse also without an important 
respiratory distress. 
In the lethal cases between the contact with the allergen and the anaphylaxis there’s a very 
short time. The anaphylaxis shows  immediately or in few minutes after the exposition; in 
the most of the cases by 15-20 minutes. Reactions after 60 minutes from the exposition are 
very rare. As soon the reaction occurs as easier the death is; sometimes death can be 
immediate and, however by 1-2 hours. More rarely death occurs by 24 hours. 
3. Proposal of a methodological protocol 
In most of the cases the diagnosis of anaphylactic death represents a challenging deal. So it’s 
very important that the anatomo-pathological and/or medico-legal investigations must be 
very scrupulous and must analyze: 
 medical history of the deceased and eventual investigations on the spot; 
 necropsy with: 
 lab tests, for which it’s better to use peripheral blood sample and not central ones;  
 histological tests 
 histochemical and immuno-histochemical tests. 
3.1 Medical history and  investigations on the spot 
To make diagnosis of anaphylactic death it’s important to make a correlation between the 
symptoms and an insect bite, the ingestion of food, drugs or other substances. 
So we should collect anamnesis by family and general practitioner, especially if related to an 
history of allergy. Some patients, however, doesn’t know to have allergies  and anaphylaxis 
is the first (and last) allergic reaction they have in their life.  
Especially in the cases with medical history negative for past allergic reaction it’s important, 
when possible, going on the spot where the death occurred to get the eventual syringes used 
for injection and/ or to evaluate the presence of nests of wasps. It’s important hearing to 
witnesses that could tell the symptoms of the victim. Sudden weakness, itching and 
urticaria, chest oppression and respiratory distress (wheezing) followed by cardio-
circulatory collapse may occur. Symptoms maybe very variable and could be involved 
almost all the functions/apparatus as we remembered before. 
3.2 Complete necroscopic exam 
It’s very important beginning with an accurate external exam to verify the presence of signs 
such as rash, urticaria or angioedema; to verify the skin integrity finding out eventual site of 
inoculation: it’s important to investigate also the sites covered by hair. If there a positive 
finding it’s opportune to proceed, during the successive autopsy, also to get a skin sample 
after the examination of the route in the case of subcutaneous or intramuscular injection. 
During the autopsy the pathological findings are often aspecific. 
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Usually we find multivisceral congestion, aspecific finding in various different types of death. 
(Barnard, 1967; Da Broi & Moreschi, 2011; Delage & Irey, 1972; Di Maio & Di Maio, 2001; 
Edston & van Hage-Hamsten, 2005; James & Austen, 1964; Low & Stables, 2006; Lu et al., 2006; 
Menchel et al, 1987; Pumphrey & Roberts, 2000; Shen et al.,2009; Yilmaz et al., 2009). 
You can find: 
 glottis edema and/or of the pharyngo-laryngeal districts; 
 congestion and/or pulmonary edema; 
 hyperinflation of the alveoli with acute emphysema; 
 endo-luminal bronchial secretions- this finding  is more frequent if there’s an asthmatic 
factor and it’s usually related to a almost immediate death;  
 hemorrhagic petechiae: it’s suggestive of an asphyxial component of the death and it’s 
usually associated with an almost immediate death. 
These  findings can change according to the allergen type, to the way of administration and 
to the time passed between the exposition and the death (Edston & van Hage-Hamsten, 
2005; Low & Stables, 2006; Pumphrey & Roberts, 2000). If the death is very fast the only 
macroscopic finding is an important multivisceral congestion associated or not with the 
petechial hemorrhages (Edston & van Hage-Hamsten, 2005; Low & Stables, 2006; Pumphrey 
& Roberts, 2000; Roberts & Pumphrey, 2001). 
In the table n. 1 there are the results of different studies present in literature (Barnard, 1967; 
Delage & Irey, 1972; Greenberger et al, 2007; James & Austen, 1964; Low & Stables, 2006; 
Pumphrey & Roberts, 2000; Shen et al.,2009; Yilmaz et al., 2009). 
 
Autopsy findings 
Study
Delage & Irey (1972) 
James & Austen 
(1964)
Barnard (1967) 
Number of cases 40 6 50 
  
3 cases 
penicillin, 1 case 
guinea-pig 
haemoglobin; 1 
case bee venom; 
1 case ragweed 
extraxt
Insect-Stings 
Erythematous skin 
rash/cutaneous 
edema 
  35 
Pulmonary 
congestion and 
edema 
36 5 35 
Upper airway 
edema 
15 4 14 
Hyperinflation of 
the lungs and/or 
mucous plugging 
of airways 
18 5 16 
Petechial 
hemorrahages
  10 
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Autopsy findings 
Study
Pumphrey & Roberts 
(2000)
Low & Stables (2006) 
Number of cases 56 18
 
Venom 
(19)
Food 
(16)
Drugs 
(21)
Venom 
(4)
Food 
(2)
Drugs  
(10)
Undetermined 
(2) 
Erythematous skin 
rash/cutaneous 
edema 
1 2 0 0 0 0 2 
Pulmonary 
congestion and 
edema 
14 9 18 3 0 5 2 
Upper airway 
oedema 
6 10 7 3 0 0 1 
Hyperinflation of 
the lungs and/or 
mucous plugging of 
airways 
7 5 3     
Petechial 
hemorrahages
4 5 1     
  
Autopsy findings 
Study
Greenberger et al. (2007) Shen et al. (2009) Yilmaz et al. (2009) 
Number of cases 25 28 36 
Erythematous skin 
rash/cutaneous 
edema 
3 4 2 
Pulmonary 
congestion and 
edema 
18 28 29 
Upper airway 
edema 
16 15 11 
Hyperinflation of 
the lungs and/or 
mucous plugging of
airways 
3 11 5 
Petechial 
hemorrahages 
6  3 
Table 1. Autopsy findings. 
A complete autopsy, with histo-pathological and chemical-toxicological investigations, is 
mandatory in every case. 
3.3 Laboratory tests  
A very useful first investigation is the research of the total and specific IgE for specific 
substances: The Igs are very stable also after death (Hieda et al, 1991).  
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The finding of total IgE doesn’t demonstrate the anaphylaxis but indicates that the subject 
was sensible for particular substances (e.g. insect venom, antibiotics, etc..). However , in 
there’s a positive history or suspect for allergies for specific substances, every suspected 
substance must be tested with specific IgE. If there isn’t an accurate anamnesis or an history 
of allergy it’s a good idea testing the most common allergens. (Calvani et al., 2007; Hamilton 
& Adkinson, 2003; Horn et al., 2004). 
A second investigation on the cadaverous blood sample is the dosage of beta-tryptase. As 
we already said, the degranulation of the mast-cells releases powerful chemical mediators 
(histamine, tryptase, etc..) (Ansari et al., 1993, Carson et al., 2009; Way & Baxendine 2002).  
The tryptases, instead, are relatively stable post-mortem  (values can remain high for some 
days in a serum sample kept at room temperature and for some months if freezed) (Joint 
Task Force on Practice Parameters et al., 1998; Horn, 2004) and their dosage is very useful in 
the diagnostics of acute anaphylaxis. As already said, in addition to mast cells also the 
basophiles produce tryptases but fewer than 300-700 times compared to skin and lung mast 
cells. So the serum concentration of tryptase is considered an index of mast cells activation. 
In particular we must determine the beta-tryptases that are usually released by mast cell 
degranulation (while the alfa-tryptase is secreted constitutively by mast cells and represent 
an index of the mast cells mass and so it is present in the mastocytosis) (Kanthawatana et al, 
1999; Schwartz 2004). 
For this reason the ratio between total tryptase (alfa + beta)  and beta-tryptase is important 
to distinguish between an episode of anaphylaxis and patients with systemic mastocytosis: a 
ratio less than 10 is usually indicative of an anaphylactic reaction while a ratio <20 suggests 
a systemic mastocytosis (Joint Task Force on Practice Parameters et al., 2005; Lieberman et 
al, 2010; Schwartz et al., 1995, Schwartz & Irani, 2000). Serum levels of tryptase quickly 
increase and  are detectable by 30 minutes (the concentration peak is reached in the first 2-3 
hours) and remain high for about 5 hours (Joint Task Force on Practice Parameters et al., 
2005; Lieberman et al, 2010). High levels of beta-tryptase point out a degranulation and, so, 
support the diagnosis of anaphylaxis.   
Usually the increase of the serum level of tryptase is bigger as much as the anaphylaxis has 
been severe. It’s important underline that the negativity of this test doesn’t exclude an 
anaphylactic death. In fact Sampson has demonstrated that the rise of this enzyme could be 
absent in the anaphylaxis by food, maybe because of the involvement of other cells such as 
basophils or monocytes/macrophages (Sampson et al., 1992). 
Therefore tryptase concentrations in femoral blood (not influenced by position at death or 
resuscitation efforts) (Edston et al., 2007) and serum chymase and tryptase levels (Nishio et 
al., 2005; Shen et al., 2002) have been suggested in postmortem cases to validate the 
diagnosis of anaphylactic deaths. 
The histamine is another product of mast cell degranulation. This mediator, even if is very 
valid in vivo (it’s an index of mast cell activation even though not specific of the mastcells 
alone) , isn’t an effective indicator after death because has a very short half-life (2 minutes). 
So the N-methylhistamine, that is a product of histamine degradation and is stable in the 
urine,  but in the cases of anaphylactic death the time is too short to find  it into the urine 
(Sthephan et al. 1990; Edston et al, 2005, 2007). 
Among the other possible tests we remember the serum titration of a mastcell-specific 
chymase (Nishio et al., 2005; Osawa et al. 2008), that is a serum protein  mainly kept into the 
mastcell granules. 
It’s important to note that the positivity to total IgE or of the serum tryptase cannot be 
considered , by the forensic profile, as a sure indication of a death by anaphylaxis because 
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the positivity of one or both the markers has been found also in other pathologies (Randall 
et al., 1995; Horn et al., 2004) such as traumatic death or the sudden infant death syndrome 
(Buckley et al., 2001; Edston et al., 1999; D’Errico et al., 2008; Holgate et al, 1994; Nishio & 
Suzuki, 2004; Schwartz, 2001) but must be integrated with the results of other investigations 
that must be done in every case of death. 
3.2 Histology 
Finally the histo-pathological diagnosis is very important and may show eosinophilia  
(Delage ande Irey, 1972) especially in the upper and lower airway, in the liver and in the 
spleen (Voigt, 1966); the presence of glottis edema and/or pharyngo-laryngeal edema that, 
histologically, could be associated with a wide dissociation of collagen fibers and of the 
glandular elements, eosinophilic infiltration and vascular congestion (Pumphrey and 
Roberts, 2000).  
Sometimes, using hematoxylin-eosin stain, there’s lung hyperinflation with emphysema, 
endo-luminar mucous and peri-bronchial congestion, edema and  eosinophilic infiltrate. 
Another method is the mast cell count in the various organs and tissues: unfortunately 
specific stainings for mast-cells  are based on the metachromatic properties of the 
cytoplasmic granules and showed limited: 
1. the positivity of the mast cells varies according the technique used to fix and stain  
(Strobel et all., 1981); 
2. the counts in the tissue ‘post-mortem’ after the anaphylaxis is underestimated because 
of the mast cells’ degranulation during anaphylaxis. The staining can’t put in evidence 
the  degranulated mast cells; so, because the number of mast cells varies from each one 
it’s impossible decide how many cells have degranulated.  
3. the base –level of mast-cell concentration  after death is strongly underestimated. 
In literature, however, there is a case (Heard et all., 1989) where  the authors compare the 
pulmonary concentration of mast-cells in the allergic subject pre- (biopsy) and post-mortem 
showing a diminution in the latter sections. 
3.3 Auxiliary techniques: histochemical and immuno-histochemical 
Since histology alone cannot give absolute results, it have been studied  more complex 
techniques such as histochemistry and immuno-histochemistry. 
In 1960 Glenner and Cohen (Glenner & Cohen, 1960) identified the proteases of mast cell 
granules using histo-chemical procedures. The main morphologic characteristic to 
distinguish mast cells is the presence, in cytoplasm, of many roundish granules, 
homogeneous in man, soluble in water, that stain methacromatically with basic dyes such as 
Toluidine blue, or with dyes for glycosaminoglycans polymerized such as Alcian blue. The 
granules are coated with membrane and contain heparin and histamine. In particular, the 
presence of heparin, an anticoagulant glycosaminoglycan, accounts for the staining of these 
granules. In the anaphylaxis the massive degranulation could be emphasized with this 
technique with the highlight of the granules next to mast cells. Furthermore it has been 
identified antibodies against histamine but they are not useful for post-mortem evaluation 
since histamine is poorly stable (Johansson et al., 1992) 
Pagoda red stain is another histo-chemical procedure successfully employed for the 
histological demonstration of several substances with fibrillar periodical structure, like 
amyloids (Battaglia et al., 1985; Yanagihara et al. 1984), cellulose, siloxanes, polysiloxanes 
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and polyethylene polymers and more rarely to put in evidence eosinophilia in various 
tissues (Kyono et al, 1982). This technique displays a mixing of cytotypes, 
contemporaneously on the same slide, easily identifiable, since degranulated mast cells and 
their outside granules appear brilliant red over a pale blue background (Trani et al., 2008). 
 
Cytotypes EMBP Chymase Tryptase CD117 Pagoda red 
Eosinophils ++ - - - +++ 
Mast cell - +++ +++ - +++ 
      - negative reaction        ++ moderate reaction      +++  strong reaction 
Table 2. Panel of identification of eosinophils and mast cells: a comparative evaluation 
(Trani et al. 2008). 
Pagoda Red stain is a dye originally employed in the industrial field to dye clothes and 
occasionally carried out in cytopathology in case of nasal (Rivasi & Bergamini, 1988) or 
ocular (Rivasi et al., 1992) allergic processes possibly related to the presence of airborne, 
nonhuman elements. 
Immuno-histo-chemical investigations although more expensive than histo-chemical ones 
allow to characterize the immuno-phenotype  of the various cells in the inflammatory 
infiltrate associated with anaphylaxis; especially specific antibodies can bind superficial 
antigens in these cells such as tryptases and chymases (Akin et al. 2007; Carson & Cook, 
2009; Irani et al., 1989; Perskvist & Edston, 2007). 
Human mast cell tryptases comprise a family of trypsin-like neutral serine proteases that are 
predominantly expressed in mast cells. This antibody is useful for the identification of very 
atypical or immature mast cells (MC) in mast cell leukemia, and for the detection of small, 
even minute, dense focal MC infiltrates in staging procedures in patients with known 
cutaneous mastocytosis. Using an avidin-biotin enhanced immunoperoxidase procedure, 
with monoclonal antibodies (AA1, AA3, and AA5) directed against human mast cell 
tryptase, it’s possible to obtain an intense staining of mast cells in paraffin-embedded tissue. 
It represents an highly specific and sensitive means for the detection of mast cells in 
routinely processed tissues. 
Chymases belong to a family of serine proteases like intracellular granule and it’s involved 
in regulating extracellular matrix proteolysis and promoting tissue remodelling (Doggrell & 
Wanstall, 2004). This substance is mainly found in mast cell cytoplasm but also outside the 
mast cells in the connective tissues surrounding vascular walls and, in less concentration, in 
basophils. (Hamada et al. 1999). Chymase antibodies is available for formaldehyde-fixed 
tissue and can be used simultaneously to tryptase by a sandwich technique applying the 
two antibody (Buckley et al. 1999). 
The eosinophilic major basic protein, also known as MBP, PRG2, a proteoglycan 2, BMPG or 
bone marrow natural killer cell activator, is a constituent of the eosinophilic granules. High 
levels of the pro-EMBP are present in pregnancy serum and in placenta where it develops a 
complex with other proteins. It may influence antiparasitic defense mechanisms as  
cytotoxin and helminthotoxin and immune hypersensitivity reactions (Trocme et al. 1989).  
The role of EMBP is to  modulate inflammation and lead to tissue destruction resulting in 
cytotoxic effects (Butterworth & David, 1981). It has been demonstrated to be elicited in 
mast cell and basophil (Trocme et al. 1989) degranulation.  
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4. Conclusions 
Post-mortem diagnosis of anaphylactic death is very difficult and it’s possible only 
excluding every other cause of death and taking into considerations the results of other 
exams: accurate medical history, complete necroscopic examination integrated with 
histological examination, lab tests, and auxiliary techniques of  histochemistry and immuno-
histo-chemistry. This diagnosis, in particular for the medico-legal aspect, cannot be based on 
the positivity of one only type of investigation (e.g. bioumoral tests) because that positivity 
can be found also in other pathologies (Horn, 2004) but must be integrated with the results 
of more investigations.   
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